Home/Filings/4/0000899243-19-028520
4//SEC Filing

WHOLIHAN EDWARD 4

Accession 0000899243-19-028520

CIK 0001624658other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 9:28 PM ET

Size

7.8 KB

Accession

0000899243-19-028520

Insider Transaction Report

Form 4
Period: 2019-12-02
WHOLIHAN EDWARD
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-12-02+153,000153,000 total
    Exercise: $2.42Exp: 2029-12-01Common Stock (153,000 underlying)
  • Award

    Restricted Stock Units

    2019-12-02+82,41182,411 total
    Common Stock (82,411 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]50% shall vest on June 2, 2020 and the remaining 50% shall vest on December 2, 2020.
  • [F3]Shares vest in 48 equal monthly installments beginning January 2, 2020.

Issuer

Allena Pharmaceuticals, Inc.

CIK 0001624658

Entity typeother

Related Parties

1
  • filerCIK 0001719764

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 9:28 PM ET
Size
7.8 KB